Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Pfizer Inc. (PFE), Alliance HealthCare Services, Inc. (AIQ), Skilled Healthcare Group, Inc. (SKH): HealthInvest Partners AB’s Largest Holdings Last Quarter

Anders Hallberg and Carl Bennet’s HealthInvest Partners AB revealed its top picks for the fourth quarter of 2014. According to the 13F Form filed with the U.S. Securities and Exchange Commission, the investment firm’s largest holdings are Pfizer Inc. (NYSE:PFE), Alliance HealthCare Services, Inc. (NASDAQ:AIQ), and Skilled Healthcare Group, Inc. (NYSE:SKH).

Pfizer Inc. (NYSE:PFE)

HealthInvest Partners is an independent Swedish fund management company, founded in 2006 by Andres Hallberg and Carl Bennet. The firm manages four specialty funds that focus on the pharmaceutical, medical technology, biotechnology, and healthcare sectors in North America and Asia. The Stockholm-based investment manager’s equity portfolio is valued at around $120 million and includes only 16 different holdings. HealthInvest Partners’ investment strategy consists of placing a strong emphasis on low valuations, while seeking out potential catalysts that could boost shareholder value, through in-depth due diligence. Furthermore, the firm does not place much faith on earnings when evaluating a stock, but focuses on free cash flow instead.

The largest position held by HealthInvest Partners by the end of 2014 was Pfizer Inc. (NYSE:PFE), representing almost 12% of its equity portfolio. The investment firm entered this new position during the fourth quarter, acquiring 465,000 shares of the company’s stock. In addition to the Swedish fund manager, numerous institutional investors are bullish regarding the $206 billion pharmaceutical behemoth. At the end of the third quarter, Ken Fisher’s Fisher Asset Management disclosed a position of 31.7 million shares, amounting to almost 2% of its equity portfolio. Cliff Asness’ AQR Capital Management even held Pfizer amongst its top 5 picks, with a stake of 10.4 million shares. Furthermore, Pfizer Inc. (NYSE:PFE) claimed a spot on ETF Channel’s Top 25 ”Dividend Giant” list, thanks to a solid 3.54% yield in 2014. HealthInvest Partners’ top pick for the fourth quarter also boasts a 70% growth rate over the past five years, making it a great long-term investment. Last year, the company was at the center of an intense debate in the pharmaceutical industry, due to the potential merger with AstraZeneca plc (ADR) (NYSE:AZN). Although speculation concerning a new deal ran high after Pfizer’s failed $118 billion bid in May, AstraZeneca has yet to receive a new offer.  

HealthInvest Partners holds a stake of 527,100 shares in Alliance HealthCare Services, Inc. (NASDAQ:AIQ), making it the second-largest position in its equity portfolio. The stock was initially acquired by the investment firm during the fourth quarter of 2013 and since then, it has lost around 20.7% of its value. Nevertheless, HealthInvest Partners remains bullish regarding the small-cap healthcare services company, which continues to generate strong cash flow. As stated above, the fund manager places greater value on the cash flow of a business, rather than on the stock’s earnings.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.